BAYER AG CEDEAR EACH 3 REP 1BAYER AG CEDEAR EACH 3 REP 1BAYER AG CEDEAR EACH 3 REP 1

BAYER AG CEDEAR EACH 3 REP 1

No trades
See on Supercharts

Key stats

Market capitalization
‪26.88 T‬ARS
Dividend yield (indicated)
Price to earnings Ratio (TTM)
Basic EPS (TTM)
Net income (FY)
Revenue (FY)
Shares float
Beta (1Y)
0.02

About BAYER AG NA O.N.

CEO
William N. Anderson
Headquarters
Leverkusen
Website
Founded
1952
ISIN
ARDEUT112414
FIGI
BBG000BZFX28
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where BAYN is featured.